{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:13:56Z","timestamp":1788902036143,"version":"build-2803163510"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>\n                    We report a 71\u2011year\u2011old woman with recurrent gastric adenocarcinoma presenting with colonic wall involvement on follow-up contrast-enhanced CT scan. Initial restaging\n                    <jats:sup>18<\/jats:sup>\n                    F\u2011FDG PET\/CT demonstrated intense colonic and omental uptake, consistent with recurrent malignancy. After chemotherapy, follow\u2011up\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT showed marked metabolic improvement; however, concurrent \u2076\u2078Ga\u2011FAPI PET\/CT revealed persistent intense uptake in the colonic wall, peritoneum, and omentum, closely resembling that observed on the prior\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT, correlating with ongoing clinical deterioration. This discordance suggests differential treatment response between tumor cells and cancer\u2011associated fibroblasts. Our findings raise the hypothesis that persistent tumor microenvironment activity may underlie therapeutic resistance, highlighting the potential value of early integration of FAP\u2011targeted strategies alongside tumor\u2011directed therapies.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006519","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:00:14Z","timestamp":1778522414000},"page":"e926-e928","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Response Assessment of Gastric Adenocarcinoma Using \u2076\u2078Ga-FAPI-46 and 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"51","author":[{"given":"Mahsa","family":"Sheikhnezami","sequence":"first","affiliation":[{"name":"Cancer Research Center, RAZAVI Hospital, Imam Reza International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Samadi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emran","family":"Askari","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Khorasanchi","sequence":"additional","affiliation":[{"name":"Cancer Research Center, RAZAVI Hospital, Imam Reza International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0290-0412","authenticated-orcid":false,"given":"Amin","family":"Saber Tanha","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"R1-20260908","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1097\/RLU.0000000000005554","article-title":"Utilizing 99mTc-FAPI-46 SPECT\/CT in detection of peritoneal carcinomatosis in gastric poorly differentiated adenocarcinoma","volume":"50","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R2-20260908","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1007\/s00330-022-09321-1","article-title":"Utility of [68Ga]FAPI-04 and [18F]FDG dual-tracer PET\/CT in the initial evaluation of gastric cancer","volume":"33","author":"Miao","year":"2022","journal-title":"Eur Radiol"},{"key":"R3-20260908","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.7150\/thno.88335","article-title":"Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis","volume":"13","author":"Ruan","year":"2023","journal-title":"Theranostics"},{"key":"R4-20260908","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40001-023-00997-9","article-title":"[68Ga]Ga-FAPI-04 PET MRI\/CT in the evaluation of gastric carcinomas compared with [18F]-FDG PET MRI\/CT: a meta-analysis","volume":"28","author":"Wang","year":"2023","journal-title":"Eur J Med Res"},{"key":"R5-20260908","first-page":"1","article-title":"Comparison of diagnostic efficacy of [68Ga]Ga-FAPI-04 and [18F]FDG PET\/CT for staging and restaging of gastric cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"R6-20260908","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1097\/RLU.0000000000005794","article-title":"Enhancing initial staging of a gastric cancer patient: the advantage of [99mTc]-FAPI-46 SPECT\/CT over conventional CT","volume":"50","author":"Elahifard","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R7-20260908","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.semcancer.2022.04.008","article-title":"Fibroblast heterogeneity in solid tumors: from single cell analysis to whole-body imaging","volume":"86","author":"Peltier","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R8-20260908","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1097\/RLU.0000000000004021","article-title":"177Lu-FAPI therapy in a patient with end-stage metastatic pancreatic adenocarcinoma","volume":"47","author":"Kaghazchi","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R9-20260908","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00259-021-05634-3","article-title":"FAP-targeted radionuclide therapy with [177Lu]Lu-FAPI-46 in metastatic nasopharyngeal carcinoma","volume":"49","author":"Fu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R10-20260908","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00259-023-06482-z","article-title":"Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment","volume":"51","author":"Yadav","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20260908","article-title":"177Lu-FAP-2286 therapy for advanced lung adenocarcinoma with multiple metastases","author":"Lin","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R12-20260908","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/RLU.0000000000004260","article-title":"FAP-targeted radionuclide therapy of advanced radioiodine-refractory differentiated thyroid cancer with multiple cycles of 177Lu-FAPI-46","volume":"47","author":"Fu","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R13-20260908","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/RLU.0000000000005255","article-title":"First experience of radionuclide therapy with 177Lu-FAPI-2286 in a patient with metastatic mediastinal sarcoma","volume":"49","author":"Banihashemian","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R14-20260908","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/RLU.0000000000005728","article-title":"177Lu-FAPI-2286 therapy in a patient with radio-iodine refractory papillary thyroid carcinoma: a favorable clinical and biochemical response","volume":"50","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:00:53Z","timestamp":1788901253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006519"}},"subtitle":["Highlighting the Role of the Tumor Microenvironment in Therapy Resistance"],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006519","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"2026-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}